⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL766976 | 0.79 | — | — | |
| SCHEMBL9335399 | 0.79 | — | — | |
| SCHEMBL7492457 | 0.72 | — | — | |
| SCHEMBL5248666 | 0.69 | — | — | |
| SCHEMBL3440747 | 0.69 | — | — | |
| SCHEMBL11074596 | 0.69 | — | — | |
| SCHEMBL239887 | 0.69 | — | — | |
| Ammonia Solution, Strong SCHEMBL20838553 | 0.65 | — | — | |
| SCHEMBL42375 | 0.63 | — | — | |
| SCHEMBL1403443 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113999206-B | Isoquinoline-1, 3-diamine analogue, preparation method, pharmaceutical composition and application thereof | 北京鑫开元医药科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-113999206-A | Isoquinoline-1, 3-diamine analogue, preparation method, pharmaceutical composition and application thereof | 北京鑫开元医药科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| US-11083710-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2021-08-10 | — | — | US | claimed |
| US-20200155696-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2020-05-21 | — | — | US | claimed |
| US-20200155695-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2020-05-21 | — | — | US | claimed |
| US-20040072964-A1 | Vinyl ether resins for structural applications | DSM IP ASSETS B.V. (NL) | 2004-04-15 | — | — | US | claimed |
| EP-0640142-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER (US) | 1998-05-20 | — | — | EP | claimed |
| US-5576199-A | CULTURE OF STREPTOMYCES UNDER AEROBIC CONDITIONS IN NUTRIENTS | PFIZER INC. (US) | 1996-11-19 | — | — | US | claimed |
| EP-0640142-A1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1995-03-01 | — | — | EP | claimed |
| EP-0276103-B1 | Process for production of B avermectins and cultures therefor | PFIZER (US) | 1993-10-20 | — | — | EP | claimed |
| WO-1993019194-A1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-09-30 | — | — | WO | claimed |
| EP-0284176-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-08-25 | — | — | EP | claimed |
| EP-0313297-B1 | PROCESS FOR PRODUCTION OF AVERMECTIN AGLYCONES AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-05-19 | — | — | EP | claimed |
| EP-0276131-B1 | NON-NATURAL DEMETHYLAVERMECTINS AND PROCESS THEREFOR | PFIZER INC. (US) | 1993-04-07 | — | — | EP | claimed |
| EP-0313297-A2 | Process for production of avermectin aglycones and cultures therefor | PFIZER INC. (US) | 1989-04-26 | — | — | EP | claimed |
| US-4816452-A | ANTIBIOTICS | BEECHAM GROUP P.L.C. (GB) | 1989-03-28 | — | — | US | claimed |
| EP-0284176-A2 | Process for production of avermectins and cultures therefor | PFIZER INC. (US) | 1988-09-28 | — | — | EP | claimed |
| EP-0276103-A2 | Process for production of B avermectins and cultures therefor | PFIZER INC. (US) | 1988-07-27 | — | — | EP | claimed |
| EP-0276131-A2 | Non-natural demethylavermectins and process therefor | PFIZER INC. (US) | 1988-07-27 | — | — | EP | claimed |
| EP-0210815-A2 | 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use | BEECHAM GROUP PLC (GB) | 1987-02-04 | — | — | EP | claimed |